Vivaldis Tocerapet 50mg (Toceranib Phosphate) Targeted Chemotherapy Tablets for Dogs

Select Variant: 1 strip (4 tablets)

Description

Provide targeted, advanced oncology care for your dog with Vivaldis Tocerapet 50mg Tablets, available online at VetMitra. Formulated by Vivaldis Animal Health, Tocerapet contains Toceranib Phosphate (50 mg), a veterinary-approved multi-kinase inhibitor that represents the Indian equivalent of the internationally recognized cancer therapy molecule Palladia. Unlike conventional cytotoxic chemotherapy agents that indiscriminately attack all rapidly dividing cells, Tocerapet is a targeted therapeutic agent. It acts on specific receptor tyrosine kinases (RTKs)—including split-kinase family members like c-KIT, VEGFR-2, PDGFR-β, and FLT-3. In canine cancers—especially Mast Cell Tumors (MCTs) where mutations in the c-KIT gene often drive aggressive cellular proliferation—Tocerapet selectively blocks aberrant signaling cascades inside neoplastic cells. Simultaneously, by inhibiting Vascular Endothelial Growth Factor (VEGFR) and Platelet-Derived Growth Factor (PDGFR), Tocerapet exerts potent anti-angiogenic effects, cutting off the microscopic blood vessel supply required for tumor growth and metastatic spread. The 50 mg strength is ideally calibrated for medium-to-large breed dogs requiring precise, weight-calculated dosing schedules.